Related Experiment Video
Updated: Sep 22, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Flaccid Brachial Monoplegia As Initial Presentation in a Patient With Progressive Multifocal Leukoencephalopathy
Lisa B Shields1, Vasudeva G Iyer2, Hilary A Highfield3
1Neurological Surgery, Norton Neuroscience Institute, Norton Healthcare, Louisville, USA.
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease caused by activation of John Cunningham virus (JCV) replication in the setting of impaired cellular immunity. A positive polymerase chain reaction (PCR) assay for JCV DNA in the cerebrospinal fluid (CSF) in conjunction with clinical findings and neuroimaging are diagnostic of PML. A false negative JCV PCR in the CSF may occur, necessitating PML confirmation by brain biopsy. We describe the unique clinical profile of a patient with no prior history of immunocompromise, referred to us for electrodiagnostic evaluation, who initially presented with rapidly progressive weakness of the right upper extremity. The unusual pattern of motor weakness suggested a conduction block or disconnection at the subcortical level. The patient was later diagnosed with atypical small cell lymphocytic lymphoma although not treated with monoclonal antibodies or other forms of chemotherapy. The CSF was negative for JCV, and PML was subsequently confirmed by brain biopsy. This case illustrates an uncommon presentation of PML and highlights the need for a high index of suspicion to diagnose PML.
Insights
Progressive multifocal leukoencephalopathy (PML) can present atypically, even in non-immunocompromised individuals. This case highlights the importance of brain biopsy for diagnosing PML when cerebrospinal fluid tests are negative.
Area of Science:
- Neurology
- Infectious Diseases
- Oncology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease.
- PML is caused by John Cunningham virus (JCV) reactivation in immunocompromised individuals.
- Diagnosis typically involves JCV DNA detection in cerebrospinal fluid (CSF) via PCR, alongside clinical and imaging findings.
Observation:
- A patient presented with rapid right upper extremity weakness, suggesting subcortical conduction block.
- The patient had no prior history of immunocompromise.
- The patient was diagnosed with atypical small cell lymphocytic lymphoma without chemotherapy or monoclonal antibody treatment.
Findings:
- Cerebrospinal fluid (CSF) testing for JCV DNA via PCR was negative.
- PML was ultimately confirmed through brain biopsy.
- This case represents an uncommon clinical presentation of PML.
Implications:
- Highlights the potential for false-negative JCV PCR results in CSF.
- Underscores the necessity of brain biopsy for definitive PML diagnosis in ambiguous cases.
- Emphasizes the need for a high index of suspicion for PML, even in the absence of overt immunocompromise.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Parkinson's Disease: Overview